Duncan Jodrell

Cancer Therapy : Clinical gH 2 AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents : Results from 2 Phase I Clinical Trials of SJG-136 ( SG 2000 )

John A. Hartley, Tim Meyer, Daniel Hochhauser, 2013 .

A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK‐0752 in pancreatic cancer

John Whitehead, Thomas Jaki, Natalie Cook, 2012, Statistics in medicine.

γ-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000)

Tim Meyer, Daniel Hochhauser, I. Puzanov, 2012, Clinical Cancer Research.

Bombesin and Substance P Analogues Differentially Regulate G-protein Coupling to the Bombesin Receptor

Christopher Haslett, C. Haslett, D. Jodrell, 2001, The Journal of Biological Chemistry.

Capecitabine as adjuvant treatment for stage III colon cancer.

Markus Abt, Joseph McKendrick, Marek Pawlicki, 2005, The New England journal of medicine.